|
KMID : 1033820000010010031
|
|
Journal of Artificial Heart Research
2000 Volume.1 No. 1 p.31 ~ p.42
|
|
|
Surgical treatments and significance of an implantable bi-ventricular assist device for end-stage heart failure
|
|
Sun Kyung
Kim Hyoung-Mook
|
|
|
Abstract
|
|
|
|
Surgical treatments for end-stage heart diseases include cardiac transplantation, mechanical circulatory assist and others. Although the cardiac transplantation has been considered as the best option of the treatments for the end-stage heart diseases, only a very small number of the patients can undergo it due to donor shortage or limited indications. Accordingly, requests for mechanical assist devices will be remained until an evolutional treatment appears. Mechanical circulatory assist devices can be divided into a temporary (IABP, VAD, ECMO, Centrifugal pump, and ECLS) and a permanent (TAH) one, and each has its own limitations in use depending on the composition of pump, cannulas and circuits. An implantable bi-ventricular assist device is a new concept of mechanical circulatory assist devices which takes the advantages as well as removes the shortcomings of the conventional circulatory assist devices. It can be used not only as a bridge to cardiac transplantation or recovery but also as a long-term life support system with preservation of the native heart. The latter can be nominated for a heterotopic total artificial heart. In addition, since the implantable bi-ventricular assist device can be used for a driving pump in various circulatory devices, it is most likely that the device can open a new horizon of the surgical treatment for end-stage heart diseases.
|
|
|
KEYWORD
|
|
|
end-stage heart disease, mechanical circulatory assist, implantable bi-ventricular device
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|